RE18012 AKTA pure System
key details
| Value | £49,392 |
|---|---|
| Status | complete |
| Category (CPV) | 38432000 |
| Deadline | 28 Mar 2018 |
| Contract start | 29 Mar 2018 |
| Contract end | 28 Jun 2019 |
| Procedure | open |
| SME suitable | No |
| OCID | ocds-b5fd17-bb585356-e703-44cb-8610-d905f8d78e76 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| GE HEALTHCARE UK LIMITED | £49,392 | 27 Mar 2018 | active |
description
The ÄKTA pure is a flexible and intuitive modular system for the reliable purification of proteins and other biomolecules. The instrument is a FPLC type system.
GE healthcare alone manufacture this type of equipment in a protein separation format to the required specification.
The Pure is the latest system that has replaced the AKTA Purifier and AKTA Explorer systems. It is compatible with LMB's existing systems (120+ units) and uses the same buffer and column stock deployed in the LMB and specifically backwardly compatible with the existing redundant AKTA Purifier systems used with in the laboratory, and most importantly able to use the existing methods and protocols deployed on the systems they are replacing. More importantly retains consistancey of expermential and research results which is vitally important.
The Pure is designed for liquid protein purification applications, rapid purity analysis in method development and drug target characterisation. The system provides reliable, high-resolution purification of target molecules. This is achieved from extremely small amounts or concentrations of starting material, all the way up to large quantity separations.
The Pure can perform effective separations from molecules as diverse as intact proteins, protein complexes, and nucleotides. It attains high sample recovery and stability as the complete flowpath is manufactured from inert and biocompatible materials. The instruments resolution is optimised by the connection of columns directly to the multiwavelength UV cell and also by minimised sample dilution in the tubing, valve, and flow cells. In addition to this the instrument has a novel pump design for flexible flow and pressure range, enabling high as well as low pressure separations making the Pure a very flexible system.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 6 Apr 2018 | Award (award) | · | d959ead7-5295-425e-ba1a-d7a5ef3264e5-209505 |
more from UK SHARED BUSINESS SERVICES LIMITED
- ACAS27482 - MH Good Practice tender · £69,730 · 29 Jul 2026
- CSP26511 - Finance Analyst · £8,319 · 29 Jul 2026
- CSP26493 - Employee Assistance Programme (EAP) · £100,000 · 29 Jul 2026
- CSP26614 - Infrastructure Support Analyst · £13,158 · 29 Jul 2026
- DDaT26031 - Load Balancing Software Licences · £73,425 · 28 Jul 2026
- PS26168 - Audit of internet services · £200,000 · 28 Jul 2026
- DDaT26377 - Financial Records Archive Environment · £26,719 · 27 Jul 2026
- CSP26704 - Workday Business Analyst · £111,150 · 27 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- PHE_Scientific_Provision of Fungitell kits, pipettes and assay plates - Variation 7 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
- Tender Survey Analysis Interpretation and Reporting · N H S Shared Business Services · £100,000
- Purchase of Genetics Analysis Platform · Scottish Government · £127,733
- UKRI- GSS24925 Tip racks trap column Competitive quotation · UK SHARED BUSINESS SERVICES LIMITED · £10,017
- GB-London: UKRI-4441 ACQUITY Premier Sample Manager - Fixed Loop with system installation · UK Research and Innovation · £25,013
- GB-London: UKRI-4382 MassFluidix HC system · UK Research and Innovation · £48,155
- Nutrition Equipment · University of Central Lancashire · £49,000
- LIAT Analyser · The Queen Elizabeth Hospital King's Lynn Nhs Foundation Trust · £29,760
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.